Streetbeat News

Partnerships

ASML

INTC

SSNLF

TSM

ASML Holding NV has started shipping components for its new high-NA EUV lithography machine to Intel Corp's D1X factory in Oregon. This move is part of Intel's strategy to lead in manufacturing technology and ASML's effort to sustain the chip industry's dependence on its equipment. The first model, Twinscan EXE:5200, costs around $275 million, with a more advanced model expected to be more expensive. Intel aims to begin production with this system in 2025. ASML's stock rose 3.52% to $755.27 following the news.

Portfolio Pulse from Anusuya Lahiri

December 22, 2023 | 12:09 pm

ACM

AECOM announced it has been selected as the delivery partner for the Eglinton Crosstown West Extension project in Toronto, which is a significant infrastructure development. This selection is likely to have a positive impact on AECOM's future revenue and business prospects.

Portfolio Pulse from Benzinga Newsdesk

December 22, 2023 | 11:58 am

TTE

TotalEnergies SE (NYSE:TTE) has agreed to sell a 25.5% stake in the Seagreen offshore wind farm to PTTEP for £522 million ($689 million), valuing the project at $4.3 billion. The deal aligns with TTE's renewable business model and post-transaction, TTE will retain a 25.5% stake. Additionally, TTE and PTTEP signed an MoU to explore renewable energy development. The Seagreen wind farm has a capacity of 1,075 MW and can power over 1.6 million homes. The transaction is expected to close after regulatory approvals. TTE shares closed up 1.79% at $68.40.

Portfolio Pulse from Lekha Gupta

December 22, 2023 | 11:38 am

NIO

Nio Inc (NYSE:NIO) has achieved its year-end goal by launching its 1,000th Power Swap station, meeting its target of 1,000 new stations for the year. The milestone station was opened at the Sha'anxi Nature Museum in Xi'an. Nio's power swap technology allows EV owners to exchange depleted batteries for charged ones in about 3 minutes, contrasting with the traditional charging approach of other EV manufacturers like Tesla, Volkswagen, and General Motors. Nio has also recently partnered with Zhejiang Geely Holding Group and Chongqing Changan Automobile Co to enhance its battery swap business.

Portfolio Pulse from Anan Ashraf

December 22, 2023 | 9:54 am

SHIBUSD

Shiba Inu (CRYPTO: SHIB) saw a significant burn rate increase with 8.53 billion SHIB, worth over $90,000, removed from circulation, marking a 161,500% surge in 24 hours. The lead developer hinted at an upcoming announcement. Additionally, SHIB partnered with D3 Global to secure the .shib domain, aiming to enhance Web3 interoperability within its ecosystem.

Portfolio Pulse from Mehab Qureshi

December 22, 2023 | 4:59 am

COCP

MRK

Cocrystal Pharma (COCP) received a termination notice from Merck (MRK) on December 15, 2023, ending their collaboration agreement from January 2, 2019. The termination will be effective on March 14, 2024, ceasing their joint development of influenza A/B antiviral compounds.

Portfolio Pulse from Charles Gross

December 21, 2023 | 10:05 pm

CGC

A study from Georgia College & State University and Kennesaw State University found that marijuana legalization correlates with improved college basketball recruiting but a decline in football recruiting. The study, published in the Journal of Sports Economics, used data from 2003 to 2019. It suggests that the NBA's lenient stance on marijuana may influence basketball recruits, while the NFL's stricter policy could deter football recruits. The study also notes the evolving policies of professional leagues, including the NBA's removal of marijuana from its banned substances list and the NFL's relaxed off-season testing. Canopy Growth Corp. (NASDAQ:CGC) is involved in research with the NHL Alumni Association on cannabinoids for post-concussion treatment.

Portfolio Pulse from Joana Scopel

December 21, 2023 | 9:30 pm

ABBV

ALPN

Alpine Immune Sciences has amended its 2020 agreement with AbbVie regarding acazicolcept. The amendment halts new enrollment in the phase 2 study for systemic lupus erythematosus. Final analysis is expected by end of 2024. AbbVie retains an option to license acazicolcept, exercisable upon receiving a data package from Alpine.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:22 pm

ABBV

ALDX

Aldeyra Therapeutics announced that AbbVie has extended the period during which it can exercise an option to enter a license agreement for reproxalap in dry eye disease. AbbVie can now exercise this option until the earlier of 10 business days post-FDA approval or 18 months from the effective date. If exercised, a $5M non-refundable payment will be credited against the upfront cash payment.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:19 pm

MRSN

Mersana Therapeutics and Merck KGaA have mutually agreed to terminate their Collaboration and Commercial License Agreement from June 23, 2014, as well as their Supply Agreement from May 30, 2018, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:17 pm